4.6 Review

Interferons-Implications in the Immune Response to Respiratory Viruses

Related references

Note: Only part of the references are listed.
Review Immunology

Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia

Helen C. Su et al.

Summary: Infection with SARS-CoV-2 can result in a wide range of clinical outcomes, from no symptoms to severe pneumonia and death. Genetic studies have shown that severe cases may be caused by defects in the type I interferon immune response or presence of autoantibodies that neutralize interferons. Virological and cellular studies have further demonstrated that SARS-CoV-2 proteins can hinder the induction or response to type I interferons, while these interferons can limit viral replication. These findings highlight the importance of sufficient type I interferon during the early stages of infection and have implications for treatment and future research.

ANNUAL REVIEW OF IMMUNOLOGY (2023)

Review Immunology

Interferon therapy and its association with depressive disorders - A review

Jing Yung Lai et al.

Summary: Interferons play a crucial role in controlling viral infections and have additional antimicrobial, antiproliferative/antitumor, and immunomodulatory effects. However, the use of IFN-alpha in treating hepatitis C can lead to neuropsychological disorders. Rating: 7 out of 10

FRONTIERS IN IMMUNOLOGY (2023)

Article Microbiology

TLR Responses in Preterm and Term Infant Cord Blood Mononuclear Cells

Jeremy Anderson et al.

Summary: Preterm infants exhibit similar TLR expression and cellular responses to both bacterial and viral TLR agonists as term infants. Although preterm infants show increased monocyte activation following LTA stimulation, there are no significant differences in overall cellular activation or cytokine response compared to term infants. Further research is needed to identify the immunological factors driving the increased susceptibility of preterm infants to severe infections and develop interventions for this vulnerable population.

PATHOGENS (2023)

Article Biochemistry & Molecular Biology

Expressions of Type I and III Interferons, Endogenous Retroviruses, TRIM28, and SETDB1 in Children with Respiratory Syncytial Virus Bronchiolitis

Pier-Angelo Tovo et al.

Summary: Interferons (IFNs) and IFN-stimulated genes (ISGs) are important for controlling viral infections, but their expression in infants with respiratory syncytial virus (RSV) bronchiolitis is not well defined.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2023)

Review Immunology

Immunology of SARS-CoV-2 infection in children

Janet Chou et al.

Summary: Children are generally resistant to severe disease resulting from SARS-CoV-2 infection, but cases of pediatric COVID-19 and a new syndrome called MIS-C can occur. Studies have identified immunological differences between children and adults in their response to SARS-CoV-2, which helps to understand the pediatric immune mechanisms to the infection.

NATURE IMMUNOLOGY (2022)

Review Cell Biology

Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design

Brandon Malone et al.

Summary: The molecular basis and complexity of coronavirus RNA-synthesizing machinery is still not fully understood. Recent research has focused on deciphering and understanding the structures, functions, and interactions of the subunits involved in SARS-CoV-2 replication and transcription. Both viral and host factors play a crucial role in coordinating RNA translation, replication, and transcription, making them potential targets for antiviral therapy.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Biology

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology

Riem Gawish et al.

Summary: Despite progress in understanding COVID-19, limited mechanistic insight into immunological factors and disease severity remains. Scientists generated a mouse-adapted SARS-CoV-2 strain, maVie16, and found that cytokine-driven immunopathology and ACE2 dependence determine disease severity. This study provides a new tool for discovering therapies.

ELIFE (2022)

Article Immunology

Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model

Yanxia Chen et al.

Summary: Older individuals are at higher risk of SARS-CoV-2 infection and severe outcomes due to impaired interferon and adaptive antibody response. They also have increased susceptibility to re-infection and limited adaptive immune response after COVID-19 mRNA vaccination.

EMERGING MICROBES & INFECTIONS (2022)

Article Medicine, General & Internal

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

You Li et al.

Summary: Respiratory syncytial virus (RSV) plays a significant role in morbidity and mortality burden globally in children aged 0-60 months, especially during the first 6 months of life and in low-income and middle-income countries. Passive immunization programs targeting RSV could have a substantial effect on reducing disease burden.

LANCET (2022)

Editorial Material Biochemical Research Methods

Animal models in SARS-CoV-2 research

Hin Chu et al.

Summary: This article discusses the main animal models that have played a key role in our understanding of the immune and viral dynamics of SARS-CoV-2.

NATURE METHODS (2022)

Article Multidisciplinary Sciences

An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells

Lindsay Broadbent et al.

Summary: This study demonstrates that an endogenously activated interferon lambda pathway can lead to resistance against SARS-CoV-2 infection. High expression levels of IFN lambda 1 and associated interferon stimulated genes are correlated with resistance to SARS-CoV-2 infection.

PLOS ONE (2022)

Article Biochemistry & Molecular Biology

SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1

Sin-Yee Fung et al.

Summary: SARS-CoV-2 NSP13 helicase broadly suppresses interferon signaling by targeting JAK1 phosphorylation of STAT1.

CELL AND BIOSCIENCE (2022)

Review Immunology

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy

Mahdi Eskandarian Boroujeni et al.

Summary: COVID-19, caused by SARS-CoV-2, is a highly infectious and deadly disease. It induces an inflammatory response in the body, causing severe damage to the lungs and other organs, and even multiple organ failure. Interferons (IFNs) play a crucial role in viral infections, but SARS-CoV-2 infection leads to dysregulated IFN response and excessive inflammatory response. Therefore, targeting IFN signaling and inflammatory cytokine signaling may be a novel therapeutic strategy for COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Severity of neonatal influenza infection is driven by type I interferon and oxidative stress

Ogan K. Kumova et al.

Summary: Neonates are more susceptible to respiratory viral infections due to inflammation at the developing pulmonary air-blood interface. IFN I play a dual role in controlling viral replication and promoting inflammation. In this study, IFN I was found to exacerbate an oxidative stress imbalance in neonatal mice, leading to increased mortality after influenza virus infection.

MUCOSAL IMMUNOLOGY (2022)

Review Virology

Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options

Mariem Znaidia et al.

Summary: SARS-CoV-2 has the ability to evade the innate immune response, leading to weak and delayed interferon (IFN) response in COVID-19 patients. This dysregulated immune response contributes to disease pathogenesis and the emergence of new variants challenges existing vaccines. Understanding the interplay between the virus and host immune system is crucial for managing and treating COVID-19 effectively.

VIRUSES-BASEL (2022)

Article Immunology

Type III Interferons, Viral Loads, Age, and Disease Severity in Young Children With Respiratory Syncytial Virus Infection

Jeanette Taveras et al.

Summary: In this study, children with milder RSV infection and those aged >6 months had higher concentrations of mucosal interferons, which may be associated with protection against severe RSV disease. Higher levels of IL6 increased the likelihood of hospitalization in older children, while higher concentrations of IFN-lambda 2/3 had the opposite effect regardless of age. Additionally, higher concentrations of CXCL10 were associated with reduced odds of hospitalization, oxygen administration, PICU admission, and prolonged hospitalization.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Influenza

Timothy M Uyeki et al.

LANCET (2022)

Review Pediatrics

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults A Systematic Review and Meta-analysis

Russell M. Viner et al.

Summary: This systematic review and meta-analysis found that children and adolescents have a 44% lower odds of secondary infection with SARS-CoV-2 compared to adults, with insufficient data to determine if children transmit the virus less than adults. Preliminary evidence suggests that children have a lower susceptibility to SARS-CoV-2 infection compared with adults, but their role in virus transmission remains unclear.

JAMA PEDIATRICS (2021)

Article Immunology

SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation

Wenjing Wang et al.

Summary: The study found that SARS-CoV-2 nsp12 suppresses host antiviral responses by attenuating specific IFN promoter activation and impacting the function of IRF3. These findings provide new insights into the viral pathogenesis.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Infectious Diseases

Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis

Boyan K. Tsankov et al.

Summary: Children with comorbidities are at higher risk of severe COVID-19 infection and associated mortality, with a significantly increased risk compared to healthy children. Obese children also have a higher risk of COVID-19 infection.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2

Jingjing Pei et al.

Summary: The nonstructural protein NS2 of human respiratory syncytial virus (RSV) inhibits host interferon responses by targeting early steps in the IFN-signaling pathway. NS2 directly interacts with inactive RIG-I and MDA5, preventing RLR ubiquitination and modulating host responses. The N terminus of NS2 is essential for binding to RIG-I and mutations in this region result in increased levels of IFN beta mRNA.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Medicine, General & Internal

Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis

Kathryn E. Lafond et al.

Summary: This study aimed to estimate the global burden of influenza-associated hospitalizations among adults worldwide. The researchers conducted a systematic review and meta-analysis, finding that influenza was associated with 14% of acute respiratory hospitalizations in adults, with over 5 million cases annually. The findings emphasize the importance of influenza vaccination, especially for older adults, in preventing severe disease and hospitalizations.

PLOS MEDICINE (2021)

Review Virology

Immunopathology of RSV: An Updated Review

Harrison C. Bergeron et al.

Summary: RSV is a major cause of respiratory tract disease in infants and the elderly, with limited therapeutic interventions and no FDA-approved vaccine. This review provides an update on the current understanding of RSV immunity and immunopathology, focusing on interferon responses, animal modeling, and correlates of protection.

VIRUSES-BASEL (2021)

Review Virology

Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection

Hi Eun Jung et al.

Summary: The global COVID-19 pandemic, caused by SARS-CoV-2, has impacted the world significantly. Excessive inflammatory immune responses play a key role in the severity of COVID-19, with potential therapeutic treatments focusing on anti-inflammatory drugs. Targeting toll-like receptors (TLRs) may hold promise in controlling hyperinflammation in COVID-19 patients.

VIRUSES-BASEL (2021)

Review Virology

JAK-STAT Pathway: A Novel Target to Tackle Viral Infections

Ifeanyi Jude Ezeonwumelu et al.

Summary: The modulation of the antiviral innate immune response through targeting the JAK-STAT pathway has been proposed for the development of novel pan-viral therapeutic strategies. Viruses have evolved diverse strategies to interfere with JAK-STAT signaling, highlighting its relevance as a potential antiviral target. Recent advances in JAK inhibitors have shown efficacy against various viral infections and may represent good candidates for drug repurposing strategies.

VIRUSES-BASEL (2021)

Article Biology

SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway

Shahanshah Khan et al.

Summary: The spike protein of SARS-CoV-2 triggers inflammation through activation of the NF-kappa B pathway. Recognition of the spike protein by TLR2 may be a potential therapeutic target for COVID-19.

ELIFE (2021)

Letter Cell Biology

SARS-CoV-2 spike protein interacts with and activates TLR41

Yingchi Zhao et al.

CELL RESEARCH (2021)

Article Medicine, General & Internal

Emerging SARS-CoV-2 variants expand species tropism to murines

Huiping Shuai et al.

Summary: The study found that the SARS-CoV-2 variant B.1.1.7 and other N501Y-carrying variants can infect wildtype mice and rats, producing high viral loads and infectious virus particles in their respiratory tract. This suggests that these variants may have evolved to expand species tropism to murines.

EBIOMEDICINE (2021)

Article Immunology

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

Paul Bastard et al.

Summary: Patients with biallelic loss-of-function variants of AIRE, suffering from APS-1, produce autoantibodies that neutralize most type I interferons, leading to a significantly increased risk of life-threatening COVID-19 pneumonia. Research has shown that in APS-1 patients with these neutralizing autoantibodies, 86% developed COVID-19 pneumonia.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Immunology

TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines

Min Zheng et al.

Summary: The study revealed that the envelope protein of SARS-CoV-2 is sensed by TLR2, leading to the production of inflammatory cytokines, and the severity of the disease is associated with the expression of TLR2 and MYD88. The findings demonstrate the critical role of TLR2 signaling in promoting proinflammatory cytokine production during coronavirus infection, providing new insights for therapeutic strategies against the ongoing COVID-19 pandemic.

NATURE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation

Lucy G. Thorne et al.

Summary: SARS-CoV-2 infection leads to broad-spectrum immunopathological diseases, exacerbated by inflammatory co-morbidities. Research shows that the virus replicates rapidly in lung epithelial cells and triggers a robust innate immune response, affecting macrophage activation through inflammatory mediators produced during infection. Further exacerbation of the local inflammatory environment occurs when macrophages or epithelial cells are primed with exogenous inflammatory stimuli.

EMBO JOURNAL (2021)

Article Multidisciplinary Sciences

The RNA sensor MDA5 detects SARS-CoV-2 infection

Natalia G. Sampaio et al.

Summary: Research has identified MDA5 as a cellular sensor for SARS-CoV-2 infection that induces type I and III IFNs, which can inhibit viral replication, but does not affect the induction of IL6 and TNF.

SCIENTIFIC REPORTS (2021)

Article Microbiology

SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

Maya Shemesh et al.

Summary: Type I interferons play a crucial role in combating viral infections, yet SARS-CoV-2 virus has evolved to disrupt immune defenses by blocking IFN beta production through six genes. Despite reducing pSTAT1 levels, the virus still activates antiviral programs and remains sensitive to added interferon, presenting a therapeutic opportunity.

PLOS PATHOGENS (2021)

Article Immunology

RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses

Takahisa Kouwaki et al.

Summary: RIG-I-like receptors (RLR), including RIG-I and MDA5, are crucial for the innate immune response to SARS-CoV-2, with both proteins involved in regulating cytokine expression. Transfection of viral RNA regions and viral proteins have effects on the immune response generation.

FRONTIERS IN IMMUNOLOGY (2021)

Article Microbiology

TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection

Daria Bortolotti et al.

Summary: (3) Our study demonstrated that both TLR3 and TLR7 play a role in regulating innate immunity during lung SARS-CoV-2 infection. Activation of TLRs led to the production of pro-inflammatory cytokines and interferons, indicating their potential as targets for early-stage infection control.

MICROORGANISMS (2021)

Article Cell Biology

Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children

Andre G. Costa-Martins et al.

Summary: In children lacking influenza-specific adaptive immunity, upregulation of interferon signaling pathways before receiving live attenuated influenza vaccine (LAIV) is associated with lower strain-specific viral loads. Additionally, children with pre-LAIV asymptomatic respiratory viral infections show differential expression of interferon-stimulated genes, which are negatively correlated with LAIV viral loads. The variability in mucosal interferon gene expression in children prior to infection may impact the course of subsequent influenza infections, possibly due to frequent respiratory viral infections.

CELL REPORTS MEDICINE (2021)

Review Cell Biology

SARS-CoV-2, COVID-19 and the aging immune system

Juliet M. Bartleson et al.

Summary: The COVID-19 pandemic poses a greater risk for severe disease and death in older adults and individuals with age-related metabolic and cardiovascular diseases. Interventions targeting immunosenescence may be crucial in reducing mortality and disability caused by the pandemic, ultimately improving complications associated with severe COVID-19 in individuals of all ages.

NATURE AGING (2021)

Article Genetics & Heredity

Decoding Covid-19 with the SARS-CoV-2 Genome

Phoebe Ellis et al.

Summary: This review summarizes details of the SARS-CoV-2 genome and discusses the origin, evolution, and diagnostic methods of this virus. The virus is believed to have originated from SARS-like CoVs in bats, but an intermediate host has not yet been identified. The key determinant of the SARS-CoV-2 genome is the spike gene, which encodes a viral structural protein that interacts with the host cell entry receptor ACE2, allowing the virus to bind to humans more easily than SARS-CoV.

CURRENT GENETIC MEDICINE REPORTS (2021)

Review Immunology

Neonatal T Cells: A Reinterpretation

Brian D. Rudd

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Article Cell Biology

Type I interferon antagonistic properties of influenza B virus polymerase proteins

Andre Schreiber et al.

CELLULAR MICROBIOLOGY (2020)

Review Immunology

Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion

Achille Broggi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Virology

Characteristics of Human OAS1 Isoform Proteins

Han Di et al.

VIRUSES-BASEL (2020)

Letter Medicine, General & Internal

SARS-CoV-2 Infection in Children

Xiaoxia Lu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Pediatrics

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Florian Goetzinger et al.

LANCET CHILD & ADOLESCENT HEALTH (2020)

Article Multidisciplinary Sciences

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Aaron J. Wilk et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

Hongjing Gu et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Activation and evasion of type I interferon responses by SARS-CoV-2

Xiaobo Lei et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Interferon-Dependent and Respiratory Virus-Specific Interference in Dual Infections of Airway Epithelia

Manel Essaidi-Laziosi et al.

SCIENTIFIC REPORTS (2020)

Article Chemistry, Medicinal

Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR/IL-1R Signaling

Lingfeng Chen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

Katharina Schubert et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Article Multidisciplinary Sciences

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Prabhu S. Arunachalam et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Article Cell Biology

Evasion of Type I Interferon by SARS-CoV-2

Hongjie Xia et al.

CELL REPORTS (2020)

Review Oncology

Roles of IFN-γ in tumor progression and regression: a review

Dragica Jorgovanovic et al.

BIOMARKER RESEARCH (2020)

Review Immunology

Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces

Megan L. Stanifer et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19

Francis K. Yoshimoto

PROTEIN JOURNAL (2020)

Article Immunology

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

Chun-Kit Yuen et al.

EMERGING MICROBES & INFECTIONS (2020)

Review Biochemistry & Molecular Biology

Differential Regulation of Type I and Type III Interferon Signaling

Megan L. Stanifer et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Microbiology

Respiratory syncytial virus entry and how to block it

Michael B. Battles et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Review Immunology

Shared and Distinct Functions of Type I and Type III Interferons

Helen M. Lazear et al.

IMMUNITY (2019)

Article Virology

Evaluation of nasal levels of interferon and clinical severity of influenza in children

Marcelo Comerlato Scotta et al.

JOURNAL OF CLINICAL VIROLOGY (2019)

Article Immunology

Severe influenza pneumonitis in children with inherited TLR3 deficiency

Hye Kyung Lim et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Article Virology

Interferon-Stimulated Genes: What Do They All Do?

John W. Schoggins

ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)

Review Immunology

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis

Jonatan J. Carvajal et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Microbiology

ISG15 in antiviral immunity and beyond

Yi-Chieh Perng et al.

NATURE REVIEWS MICROBIOLOGY (2018)

Review Immunology

Human genetics of infectious diseases: Unique insights into immunological redundancy

Jean-Laurent Casanova et al.

SEMINARS IN IMMUNOLOGY (2018)

Article Infectious Diseases

Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains

Alberto J. Leon et al.

PLOS NEGLECTED TROPICAL DISEASES (2018)

Review Immunology

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

Flavia Castro et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Medicine, General & Internal

Influenza

Florian Krammer et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Immunology

Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency

Nicholas Hernandez et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Immunology

Type III Interferons in Antiviral Defenses at Barrier Surfaces

Alexandra I. Wells et al.

TRENDS IN IMMUNOLOGY (2018)

Review Immunology

The Role of Interferons in Inflammation and Inflammasome Activation

Natasa Kopitar-Jerala

FRONTIERS IN IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency

Michael J. Ciancanelli et al.

SCIENCE (2015)

Article Virology

Influenza virus activation of the interferon system

Marian J. Killip et al.

VIRUS RESEARCH (2015)

Article Respiratory System

Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice

Katherine M. Eichinger et al.

RESPIRATORY RESEARCH (2015)

Review Immunology

Type I interferons in infectious disease

Finlay McNab et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Respiratory System

Pulmonary arterial hypertension in patients treated with interferon

Laurent Savale et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Article Immunology

The CD4 T cell response to respiratory syncytial virus infection

Allison F. Christiaansen et al.

IMMUNOLOGIC RESEARCH (2014)

Article Infectious Diseases

Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis

Carla Selvaggi et al.

JOURNAL OF INFECTION (2014)

Review Immunology

Ontogeny of early life immunity

David J. Dowling et al.

TRENDS IN IMMUNOLOGY (2014)

Article Multidisciplinary Sciences

Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions

Swantje Liedmann et al.

NATURE COMMUNICATIONS (2014)

Article Education, Scientific Disciplines

Pattern recognition receptors in innate immunity, host defense, and immunopathology

Rahul Suresh et al.

ADVANCES IN PHYSIOLOGY EDUCATION (2013)

Review Pharmacology & Pharmacy

IFN- subtypes: distinct biological activities in anti-viral therapy

K. Gibbert et al.

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Article Infectious Diseases

Role of human Toll-like receptors in naturally occurring influenza A infections

Nelson Lee et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)

Review Microbiology

Mx Proteins: Antiviral Gatekeepers That Restrain the Uninvited

Judith Verhelst et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2013)

Article Multidisciplinary Sciences

Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection

John S. Tregoning et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

The influenza virus PB1-F2 protein has interferon antagonistic activity

Sabine E. Dudek et al.

BIOLOGICAL CHEMISTRY (2011)

Review Biochemistry & Molecular Biology

The Interferon Inducible Gene: Viperin

Katherine A. Fitzgerald

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)

Review Immunology

Therapeutic targeting of respiratory syncytial virus G-protein

Lawrence M. Kauvar et al.

IMMUNOTHERAPY (2010)

Editorial Material Biochemistry & Molecular Biology

Interferon-Lambda: A New Addition to an Old Family

Raymond P. Donnelly et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)

Article Multidisciplinary Sciences

IFN-γ produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine

Elodie Mohr et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Immunology

The roles of TLRs, RLRs and NLRs in pathogen recognition

Taro Kawai et al.

INTERNATIONAL IMMUNOLOGY (2009)

Article Immunology

Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults

Tobias R. Kollmann et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Immunology

Activation of innate immune antiviral responses by Nod2

Ahmed Sabbah et al.

NATURE IMMUNOLOGY (2009)

Review Immunology

Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells

Habib Zaghouani et al.

TRENDS IN IMMUNOLOGY (2009)

Review Biochemistry & Molecular Biology

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history

Patricia Fitzgerald-Bocarsly et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2008)

Article Immunology

The biology of influenza viruses

Nicole M. Bouvier et al.

VACCINE (2008)

Article Immunology

Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function

Shawn Rose et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Biochemistry & Molecular Biology

Interferon-inducible Mx gene expression in cotton rats: Cloning, characterization, and expression during influenza viral infection

Lioubov M. Pletneva et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)

Review Immunology

Mechanisms of type-I- and type-II-interferon-mediated signalling

LC Platanias

NATURE REVIEWS IMMUNOLOGY (2005)

Article Multidisciplinary Sciences

T-bet is required for optimal production of IFN-γ and antigen-specific T cell activation by dendritic cells

G Lugo-Villarino et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Immunology

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

RA Tripp et al.

NATURE IMMUNOLOGY (2001)